Curis Inc
(NAS:CRIS)
$
3.96
-0.18 (-4.35%)
Market Cap: 35.05 Mil
Enterprise Value: 15.09 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 48/100 Curis Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 10, 2021 / 03:00PM GMT
Release Date Price:
$174.4
(+4.93%)
Jason Russell
Morgan Stanley - MD
And thanks for joining. My name is Jason Russell with the biotech investment banking team. And it's absolutely my pleasure to host this fireside chat with Jim, the CEO of Curis.
Before we jump in, a quick disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
With that, Jim, welcome, and thanks for being here with us today.
James E. Dentzer
Curis, Inc. - President, CEO & Director
Thank you for having us. Really appreciate it.
Questions & Answers
Jason Russell
Morgan Stanley - MD
Yes. Listen, it's -- maybe just jump right in. You've had a really incredible 12 months as a company.
James E. Dentzer
Curis, Inc. - President, CEO & Director
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot